Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor

Rong Hu, Wanli Wang, Ying-Yue Yang, Xia-Tong Hu, Qiwei Wang, Weiqiong Zuo, Ying Xu, Qiang Feng, Ningyu Wang

European Journal of Medicinal Chemistry · 2021 · 47 citations · 38 references

DOIFull text

Open access

Concepts

References

38